[This corrects the article DOI: 10.3389/fonc.2022.965168.].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11325847 | PMC |
| http://dx.doi.org/10.3389/fonc.2024.1469606 | DOI Listing |
Publication Analysis
Top Keywords
erratum extensive
4
extensive patient-to-patient
4
patient-to-patient single
4
single nucleus
4
nucleus transcriptome
4
transcriptome heterogeneity
4
heterogeneity pheochromocytomas
4
pheochromocytomas paragangliomas
4
paragangliomas [this
4
[this corrects
4
Similar Publications
Correction: Efficacy and safety analysis of anlotinib in combination with immune checkpoint inhibitors for second-line and subsequent extensive-stage small-cell lung cancer.
Neoplasma
October 2024
Graduate School, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Article Synopsis
- - The editorial department of NEOPLASMA has made a correction regarding the author's affiliation due to a previous request from the university and issues with timing.
- - The first author’s affiliation was updated to comply with the Office of Zhejiang Chinese Medical University's standards for English translation.
- - The correction specifically changed the affiliation from "Graduate School of Zhejiang University of Traditional Chinese Medicine" to "Graduate School, Zhejiang Chinese Medical University."
Corrigendum: Childhood cerebral visual impairment subtype classification based on an extensive versus a limited test battery.
Front Neurosci
August 2024
Royal Dutch Visio, National Foundation for the Visually Impaired and Blind, Huizen, Netherlands.
[This corrects the article DOI: 10.3389/fnins.2023.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!